IRL is dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). IRL strives to transform the everyday life for patients who lack effective treatment options. Their purpose derives from the great medical need for safe and efficient treatments of diseases related to the central nervous system.
Integrative Research Laboratories Sweden (IRL)
IRL’s mission is to provide novel treatments in the field of primary neurodegenerative disorders.